We have located links that may give you full text access.
Retinol binding protein 4 and risk of type 2 diabetes in Singapore Chinese men and women: a nested case-control study.
Background: Although retinol binding protein 4 (RBP4) has been implicated in insulin resistance in experimental studies, the association between RBP4 and risk of type 2 diabetes remains unclear. We assessed this association in a Chinese population, and pooled our results with those from two prior studies.
Methods: Plasma RBP4 levels were measured among 571 incident type 2 diabetes cases and 571 controls nested within the Singapore Chinese Health Study. All participants were free of diabetes, cancer and cardiovascular disease at blood collection (1999-2004). Incident cases of physician-diagnosed diabetes were self-reported at subsequent interviews (2006-2010).
Results: Plasma RBP4 levels were significantly higher in men than women, and the respective median values were 30 (interquartile range: 24-35) μg/mL and 25 (interquartile range: 21-31) μg/mL, respectively. With adjustment for diabetes risk factors, compared to the lowest quartile, the odds ratio (OR) and confidence interval (CI) for risk of type 2 diabetes associated with the highest quartile of RBP4 levels were 1.23 (0.73-2.07; P -trend = 0.14) in all subjects, 0.63 (0.27-1.45; P -trend = 0.65) in men, and 2.29 (1.05-5.00; P -trend = 0.018) in women. The difference in the risk estimates between men and women was statistically significant ( P -interaction = 0.032). When we pooled our results with two prior studies, ORs (95% CIs) comparing high versus low category of RBP4 was 1.01 (0.70-1.46; I 2 = 8.2%; P -heterogeneity = 0.34) in men, and 1.73 (1.28-2.33; I 2 = 0%; P -heterogeneity = 0.80) in women.
Conclusions: Increased plasma RBP4 levels were associated with higher risk of type 2 diabetes in women but not in men.
Methods: Plasma RBP4 levels were measured among 571 incident type 2 diabetes cases and 571 controls nested within the Singapore Chinese Health Study. All participants were free of diabetes, cancer and cardiovascular disease at blood collection (1999-2004). Incident cases of physician-diagnosed diabetes were self-reported at subsequent interviews (2006-2010).
Results: Plasma RBP4 levels were significantly higher in men than women, and the respective median values were 30 (interquartile range: 24-35) μg/mL and 25 (interquartile range: 21-31) μg/mL, respectively. With adjustment for diabetes risk factors, compared to the lowest quartile, the odds ratio (OR) and confidence interval (CI) for risk of type 2 diabetes associated with the highest quartile of RBP4 levels were 1.23 (0.73-2.07; P -trend = 0.14) in all subjects, 0.63 (0.27-1.45; P -trend = 0.65) in men, and 2.29 (1.05-5.00; P -trend = 0.018) in women. The difference in the risk estimates between men and women was statistically significant ( P -interaction = 0.032). When we pooled our results with two prior studies, ORs (95% CIs) comparing high versus low category of RBP4 was 1.01 (0.70-1.46; I 2 = 8.2%; P -heterogeneity = 0.34) in men, and 1.73 (1.28-2.33; I 2 = 0%; P -heterogeneity = 0.80) in women.
Conclusions: Increased plasma RBP4 levels were associated with higher risk of type 2 diabetes in women but not in men.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app